Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children.
Lauren M ByrneJordan L SchultzFilipe Brogueira RodriguesEllen van der PlasDouglas R LangbehnPeggy C NopoulosEdward J WildPublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
Quantifying plasma NfL concentration may assist clinical diagnosis and therapeutic trial design in the pediatric population. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.